These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6401389)

  • 1. Nonexudative diarrhea after gold salt therapy: case report and review of the literature.
    Nagler J; Paget SA
    Am J Gastroenterol; 1983 Jan; 78(1):12-4. PubMed ID: 6401389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold-induced colitis: a case report and review of the literature.
    Teodorescu V; Bauer J; Lichtiger S; Chapman M
    Mt Sinai J Med; 1993 May; 60(3):238-41. PubMed ID: 8345852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterocolitis complicating chrysotherapy. Case report and review of the literature.
    Sukenik S; Hirsch M; Yanai-Inbar I; Krawiec J; Freund B; Horowitz Y
    Isr J Med Sci; 1982 Oct; 18(10):1040-3. PubMed ID: 6816751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fatal pulmonary fibrosis caused by gold therapy?].
    Chatzigiannis I; Schmidt KL; Stambolis C
    Z Rheumatol; 1984; 43(2):49-58. PubMed ID: 6428074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ulcerative colitis caused by oral gold therapy in rheumatoid arthritis].
    Bross-Bach U; Saal JG; Hartmann F; Müller CA; Waller HD
    Z Rheumatol; 1987; 46(4):201-4. PubMed ID: 3118590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholestatic jaundice induced by gold salts treatment clinical and immunological aspects--report of one case and review of the literature.
    Schapira D; Nahir M; Scharf Y; Pollack S
    J Rheumatol; 1984 Dec; 11(6):843-5. PubMed ID: 6440983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities.
    van Riel PL; Gribnau FW; van de Putte LB; Yap SH
    J Rheumatol; 1983 Apr; 10(2):222-6. PubMed ID: 6408256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fatal drug-induced Lyell syndrome in combined benoxaprofen-aurothioglucose therapy].
    Braun-Falco O; Balda BR; Korting HC; Blick U; Loeschke K; Begemann F
    MMW Munch Med Wochenschr; 1982 Sep; 124(35):757-9. PubMed ID: 6813706
    [No Abstract]   [Full Text] [Related]  

  • 9. Gold-induced enterocolitis. Case report and literature review.
    Stein HB; Urowitz MB
    J Rheumatol; 1976 Mar; 3(1):21-6. PubMed ID: 818378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [2 cases of kidney damage during the treatment with gold preparations].
    Wanic-Kossowska M; Turczak-Bierła I; Grzegorzewska A
    Przegl Lek; 1990; 47(11):788-90. PubMed ID: 2129137
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic interstitial nephritis associated with gold therapy.
    Cramer CR; Hagler HK; Silva FG; Eigenbrodt EH; Meltzer JI; Pirani CL
    Arch Pathol Lab Med; 1983 May; 107(5):258-63. PubMed ID: 6404236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold-associated thrombocytopenia. Report six cases.
    Deren B; Masi R; Weksler M; Nachman RL
    Arch Intern Med; 1974 Dec; 134(6):1012-5. PubMed ID: 4611368
    [No Abstract]   [Full Text] [Related]  

  • 13. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC; Osborn TG
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
    Bernhard GC
    J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold in the dermis following gold therapy for rheumatoid arthritis.
    Cox AJ; Marich KW
    Arch Dermatol; 1973 Nov; 108(5):655-7. PubMed ID: 4201477
    [No Abstract]   [Full Text] [Related]  

  • 16. Gold induced ulcerative proctitis: report and review of the literature.
    Marcuard SP; Ehrinpreis MN; Fitter WF
    J Rheumatol; 1987 Feb; 14(1):142-4. PubMed ID: 3106630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.
    Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP; Rasker JJ; de Rooij DJ
    J Rheumatol; 1983 Dec; 10(6):948-53. PubMed ID: 6420562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J; Davis P; Owen ET
    J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and toxicity of retreatment with gold salts: a retrospective review of 25 cases.
    Sagransky DM; Greenwald RA
    J Rheumatol; 1980; 7(4):474-8. PubMed ID: 6775078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.